Moderna is soaring after promising results for its cancer vaccine. Plus, Target may be victim to profit-taking.Moderna is soaring after promising results for its cancer vaccine. Plus, Target may be victim to profit-taking.Â
Your trusted source for real-time market insights, expert analysis, and breaking financial news. We deliver actionable updates on global markets, stocks, crypto, and economic trends empowering investors to make informed decisions every day.
Contact us: contact@financeworld-news.com
© Copyright 2025 - financeworld-news.com